Sectors
FATE
Fate Therapeutics, Inc.
2.38
2 x 1.91
2 x 3.28
bid
ask
-
0.05
1.85%
10:25 AM
timesize
| Ytd | 143.37% | |
| 1y | 129.33% |
2.38
day range
2.44
0.93
52 week range
3.23
| Open | 2.40 | Prev Close | 2.43 | Low | 2.38 | High | 2.44 | Mkt Cap | 285.77M |
| Vol | 81.35K | Avg Vol | 3.18M | EPS | -1.05 | P/E | N/A | Forward P/E | -0.99 |
| Beta | 2.52 | Short Ratio | 3.10 | Inst. Own | 102.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.60 | 200-d Avg | 1.69 | 1yr Est | 6.31 |
| Income Statement | |||
| Total Revenue | 2.08M | ||
| Revenues (USD) | 2.08M | ||
| Gross Profit | 2.08M | ||
| Operating Expenses | 33.22M | ||
| Research and Development Expense | 24.39M | ||
| Selling, General and Administrative Expense | 8.83M | ||
| Operating Income | -31.13M | ||
| Net Income | -30.16M | ||
| Net Income Common Stock | -30.16M | ||
| Net Income Common Stock (USD) | -30.16M | ||
| Consolidated Income | -30.16M | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -30.16M | ||
| Earning Before Interest & Taxes (USD) | -30.16M | ||
| Weighted Average Shares | 120.40M | ||
| Weighted Average Shares Diluted | 120.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 42.48M | ||
| Cash and Equivalents (USD) | 42.48M | ||
| Investments | 121.34M | ||
| Investments Current | 121.34M | ||
| Trade and Non-Trade Receivables | 703.00K | ||
| Current Assets | 157.95M | ||
| Property, Plant & Equipment Net | 92.10M | ||
| Total Assets | 260.10M | ||
| Debt Current | 4.92M | ||
| Total Debt | 75.68M | ||
| Current Liabilities | 32.59M | ||
| Debt Non-Current | 70.75M | ||
| Total Liabilities | 106.67M | ||
| Accumulated Retained Earnings (Deficit) | -1.60B | ||
| Accumulated Other Comprehensive Income | -117.00K | ||
| Shareholders Equity | 153.44M | ||
| Shareholders Equity (USD) | 153.44M | ||
| Assets Non-Current | 102.15M | ||
| Total Debt (USD) | 75.68M | ||
| Liabilities Non-Current | 74.07M | ||
| Trade and Non-Trade Payables | 3.26M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.78M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.14M | ||
| Capital Expenditure | -80.00K | ||
| Net Cash Flow from Investing | 14.56M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.64M | ||
| Net Cash Flow from Operations | -23.43M | ||
| Share Based Compensation | 3.52M | ||